Ares Management: The Fears Are Understood, The Discount Has Overshot

Ares Management has corrected about 34% from its highs, but the article argues the selloff is excessive given resilient fundamentals. Q1 2026 management fees rose 22% year over year, FRE margin expanded to 42.4%, and fundraising hit a record, while roughly 85% of AUM is in locked or long-dated vehicles that help insulate cash flows from credit stress. The combination of earnings resilience and strong institutional demand supports a buy view on ARES.

Analysis

The key market error is treating ARES like a pro-cyclical credit beta when the fee base is increasingly annuity-like. With most assets sitting in locked or long-duration vehicles, the real earnings sensitivity is less about near-term mark-to-market noise and more about the fundraising pipeline; that shifts the stock’s fundamental clock from days to quarters. If institutional demand remains intact, the current drawdown is likely a sentiment dislocation rather than a balance-sheet problem.

Second-order, ARES benefits if private-market capital remains scarce and volatile in public markets. Allocators under pressure to diversify away from listed credit and bank lending should favor managers with stable fee growth and broad product breadth, which can pull incremental flows away from smaller private-credit competitors that rely more heavily on fresher vintages and shorter-duration capital. In that sense, weakness in the shares may actually widen ARES’s competitive moat by keeping distribution channels active while weaker platforms struggle to reset fundraising.

The contrarian risk is that the market may be correctly anticipating a slower second half in deployment, not a collapse in demand. If spreads tighten or deal volume stays muted, fee growth can stay positive while performance fees and headline momentum lag, leaving the stock range-bound for months despite resilient operating metrics. A second risk is style de-rating: if investors continue to de-risk anything labeled private credit, ARES can stay cheap longer than fundamentals justify.

Catalyst-wise, the next leg is likely to be driven by three events: continued fundraising confirmation, commentary on deployment cadence, and any evidence that fee-related earnings are compounding faster than consensus models. Over 1-3 months, the setup favors a squeeze higher if the market realizes earnings durability is not being impaired by credit stress. Over 12 months, the asymmetry improves further if fundraising translates into a larger, more durable fee base that compounds through a softer macro backdrop.

Key Decisions for Investors

• Buy ARES on weakness over the next 1-3 weeks; target a 15-20% rebound if the market re-rates the name back toward fee-growth comp multiples, with downside limited by resilient recurring fees.
• Use a bull call spread in ARES for 3-6 months out; structure for upside participation while capping premium if the stock remains range-bound due to private-markets sentiment drag.
• Pair trade: long ARES / short a smaller, less diversified private-credit manager or external asset manager with shorter-duration capital sensitivity; expect relative outperformance if fundraising remains concentrated in scaled platforms over the next 2 quarters.
• If already long, add only after the next fundraising/deployment update; this is a catalyst-driven setup, and the cleanest entry is on post-print consolidation rather than chasing a relief rally.
• For hedgers, short-dated puts only make sense if credit spreads begin widening materially; absent that, the stock’s main risk is valuation compression, not earnings breakdown.